Trials / Completed
CompletedNCT03929224
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Postoperative medicinal grade honey in post-operative care may prevent bone anchored hearing aid associated skin breakdown better than standard care of bacitracin ointment alone in adult patients.
Detailed description
This is a prospective study. Multiple surgeons will perform the bone anchored hearing aids (BAHI) implantation surgery. Patients will be randomized to either postoperative medicinal honey or postoperative standard care of bacitracin ointment alone using a random number generator. There will be a total of two patient groups. The type of BAHI device used, laterally and the surgical technique will be recorded. Treatment groups: Group 1-patients undergoing BAHI implantation who will be postoperatively treated with medicinal honey. Group 2- patients undergoing BAHI implantation who will be postoperatively treated with bacitracin ointment as standard care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Medicinal honey | Treat healing surgical site with medicinal honey |
| DRUG | Bacitracin | Treat healing surgical site with bacitracin |
Timeline
- Start date
- 2018-10-25
- Primary completion
- 2020-09-01
- Completion
- 2020-09-01
- First posted
- 2019-04-26
- Last updated
- 2026-01-07
- Results posted
- 2022-08-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03929224. Inclusion in this directory is not an endorsement.